| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $11.9M | -19.7% |
| SG&A Expense | $18.2M | +19.3% |
| Operating Income | -$42.0M | -14.3% |
| Pre-tax Income | -$38.8M | -21.5% |
| Income Tax | $576K | +0.0% |
| Net Income | -$39.4M | -21.2% |
| EPS (Basic) | -$5.97 | -7.2% |
| EPS (Diluted) | -$5.97 | -7.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | -87.7% |
| Inventory | $8.3M | — |
| Current Assets | $14.2M | -58.6% |
| Total Assets | $116.7M | +12.6% |
| Current Liabilities | $35.8M | +519.7% |
| Total Liabilities | $42.5M | +249.4% |
| Stockholders' Equity | $70.1M | -22.8% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.2M | +3.0% |
| Investing Cash Flow | -$5.0M | — |
| Financing Cash Flow | $10.0M | -27.9% |